Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical
Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical GlobeNewswire January 07, 2026 Amsterdam, the Netherlands, January 7, 2026 – Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical Co., Ltd. to utilize Scenic's Cell-Seq platform for the discovery of […]